Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1996 Jan;70(1):313–320. doi: 10.1128/jvi.70.1.313-320.1996

Expression of an equine herpesvirus 1 ICP22/ICP27 hybrid protein encoded by defective interfering particles associated with persistent infection.

M Chen 1, R N Harty 1, Y Zhao 1, V R Holden 1, D J O'Callaghan 1
PMCID: PMC189819  PMID: 8523542

Abstract

Defective interfering (DI) particles of equine herpesvirus type 1 (EHV-1) are capable of mediating persistent infection (S. A. Dauenhauer, R. A. Robinson, and D. J. O'Callaghan, J. Gen. Virol. 60:1-14, 1982; R. A. Robinson, R. B. Vance, and D. J. O'Callaghan, J. Virol. 36:204-219, 1980). Sequence analysis of cloned DI particle DNA revealed that portions of two regulatory genes, ICP22 (IR4) and ICP27 (UL3), are linked in frame to form a unique hybrid open reading frame (ORF). This hybrid ORF, designated as the IR4/UL3 gene, encodes the amino-terminal 196 amino acids of the IR4 protein (ICP22 homolog) and the carboxy-terminal 68 amino acids of the UL3 protein (ICP27 homolog). Portions of DNA sequences encoding these two regulatory proteins, separated by more than 115 kbp in the standard virus genome, were linked presumably by a homologous recombination event between two identical 8-bp sequences. Reverse transcriptase-PCR and S1 nuclease analyses revealed that this unique ORF is transcribed by utilizing the transcription initiation site of ICP22 and the polyadenylation signal of ICP27 in DI particle-enriched infection. Immunoprecipitation and Western blot (immunoblot) analyses with antisera to the ICP22 and ICP27 proteins demonstrated that a 31-kDa hybrid protein was synthesized in the DI particle-enriched infection but not in standard virus infection. This 31-kDa hybrid protein was expressed at the same time as the ICP22 protein in DI particle-enriched infection and migrated at the same location on polyacrylamide gel electrophoresis as the protein expressed from a cloned IR4/UL3 expression vector. These observations suggested that the unique IR4/UL3 hybrid gene is expressed from the DI particle genome and may play a role in DI particle-mediated persistent infection.

Full Text

The Full Text of this article is available as a PDF (468.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmed R., Canning W. M., Kauffman R. S., Sharpe A. H., Hallum J. V., Fields B. N. Role of the host cell in persistent viral infection: coevolution of L cells and reovoirus during persistent infection. Cell. 1981 Aug;25(2):325–332. doi: 10.1016/0092-8674(81)90050-7. [DOI] [PubMed] [Google Scholar]
  2. Barrett A. D., Dimmock N. J. Defective interfering viruses and infections of animals. Curr Top Microbiol Immunol. 1986;128:55–84. doi: 10.1007/978-3-642-71272-2_2. [DOI] [PubMed] [Google Scholar]
  3. Baumann R. P., Dauenhauer S. A., Caughman G. B., Staczek J., O'Callaghan D. J. Structure and genetic complexity of the genomes of herpesvirus defective-interfering particles associated with oncogenic transformation and persistent infection. J Virol. 1984 Apr;50(1):13–21. doi: 10.1128/jvi.50.1.13-21.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Baumann R. P., Staczek J., O'Callaghan D. J. Cloning and fine mapping the DNA of equine herpesvirus type one defective interfering particles. Virology. 1986 Sep;153(2):188–200. doi: 10.1016/0042-6822(86)90022-x. [DOI] [PubMed] [Google Scholar]
  5. Baumann R. P., Staczek J., O'Callaghan D. J. Equine herpesvirus type 1 defective-interfering (DI) particle DNA structure: the central region of the inverted repeat is deleted from DI DNA. Virology. 1987 Jul;159(1):137–146. doi: 10.1016/0042-6822(87)90356-4. [DOI] [PubMed] [Google Scholar]
  6. Baumann R. P., Yalamanchili V. R., O'Callaghan D. J. Functional mapping and DNA sequence of an equine herpesvirus 1 origin of replication. J Virol. 1989 Mar;63(3):1275–1283. doi: 10.1128/jvi.63.3.1275-1283.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Block T., Jordan R., Farkas D. H., Hughes R. G., Jr Inhibition of transient gene expression with plasmids encoding herpes simplex virus type 1 UL55 and alpha genes. J Gen Virol. 1991 Jan;72(Pt 1):131–141. doi: 10.1099/0022-1317-72-1-131. [DOI] [PubMed] [Google Scholar]
  8. Campbell D. E., Kemp M. C., Perdue M. L., Randall C. C., Gentry G. A. Equine herpesvirus in vivo: cyclic production of a DNA density variant with repetitive sequences. Virology. 1976 Feb;69(2):737–750. doi: 10.1016/0042-6822(76)90502-x. [DOI] [PubMed] [Google Scholar]
  9. Cattaneo R., Schmid A., Eschle D., Baczko K., ter Meulen V., Billeter M. A. Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell. 1988 Oct 21;55(2):255–265. doi: 10.1016/0092-8674(88)90048-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. DOLL E. R., RICHARDS M. G., WALLACE M. E. Adaptation of the equine abortion virus to suckling Syrian hamsters. Cornell Vet. 1953 Oct;43(4):551–558. [PubMed] [Google Scholar]
  11. Dauenhauer S. A., Robinson R. A., O'Callaghan D. J. Chronic production of defective-interfering particles by hamster embryo cultures of herpesvirus persistently infected and oncogenically transformed cells. J Gen Virol. 1982 May;60(Pt 1):1–14. doi: 10.1099/0022-1317-60-1-1. [DOI] [PubMed] [Google Scholar]
  12. Frenkel N., Jacob R. J., Honess R. W., Hayward G. S., Locker H., Roizman B. Anatomy of herpes simplex virus DNA. III. Characterization of defective DNA molecules and biological properties of virus populations containing them. J Virol. 1975 Jul;16(1):153–167. doi: 10.1128/jvi.16.1.153-167.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Furnari F. B., Zacny V., Quinlivan E. B., Kenney S., Pagano J. S. RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanism. J Virol. 1994 Mar;68(3):1827–1836. doi: 10.1128/jvi.68.3.1827-1836.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gray W. L., Baumann R. P., Robertson A. T., O'Callaghan D. J., Staczek J. Characterization and mapping of equine herpesvirus type 1 immediate early, early, and late transcripts. Virus Res. 1987 Sep;8(3):233–244. doi: 10.1016/0168-1702(87)90018-9. [DOI] [PubMed] [Google Scholar]
  15. Gray W. L., Yalamanchili R., Raengsakulrach B., Baumann R. P., Staczek J., O'Callaghan D. J. Viral transcripts in cells infected with defective interfering particles of equine herpesvirus type 1. Virology. 1989 Sep;172(1):1–10. doi: 10.1016/0042-6822(89)90101-3. [DOI] [PubMed] [Google Scholar]
  16. Hardwicke M. A., Vaughan P. J., Sekulovich R. E., O'Conner R., Sandri-Goldin R. M. The regions important for the activator and repressor functions of herpes simplex virus type 1 alpha protein ICP27 map to the C-terminal half of the molecule. J Virol. 1989 Nov;63(11):4590–4602. doi: 10.1128/jvi.63.11.4590-4602.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Harty R. N., Caughman G. B., Holden V. R., O'Callaghan D. J. Characterization of the myristylated polypeptide encoded by the UL1 gene that is conserved in the genome of defective interfering particles of equine herpesvirus 1. J Virol. 1993 Jul;67(7):4122–4132. doi: 10.1128/jvi.67.7.4122-4132.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Harty R. N., Holden V. R., O'Callaghan D. J. Transcriptional and translational analyses of the UL2 gene of equine herpesvirus 1: a homolog of UL55 of herpes simplex virus type 1 that is maintained in the genome of defective interfering particles. J Virol. 1993 Apr;67(4):2255–2265. doi: 10.1128/jvi.67.4.2255-2265.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Harty R. N., O'Callaghan D. J. Identification and expression of the UL1 gene product of equine herpesvirus 1. Virus Res. 1992 Sep 1;25(1-2):105–116. doi: 10.1016/0168-1702(92)90103-g. [DOI] [PubMed] [Google Scholar]
  20. Harty R. N., Yalamanchili R. R., O'Callaghan D. J. Transcriptional analysis of the UL1 gene of equine herpesvirus 1: a gene conserved in the genome of defective interfering particles. Virology. 1991 Aug;183(2):830–833. doi: 10.1016/0042-6822(91)91020-h. [DOI] [PubMed] [Google Scholar]
  21. Henry B. E., Newcomb W. W., O'Callaghan D. J. Alterations in virus protein synthesis and capsid production in infection with DI particles of herpesvirus. J Gen Virol. 1980 Apr;47(2):343–353. doi: 10.1099/0022-1317-47-2-343. [DOI] [PubMed] [Google Scholar]
  22. Henry B. E., Newcomb W. W., O'Callaghan D. J. Biological and biochemical properties of defective interfering particles of equine herpesvirus type 1. Virology. 1979 Jan 30;92(2):495–506. doi: 10.1016/0042-6822(79)90152-1. [DOI] [PubMed] [Google Scholar]
  23. Henry B. E., Robinson R. A., Dauenhauer S. A., Atherton S. S., Hayward G. S., O'Callaghan D. J. Structure of the genome of equine herpesvirus type 1. Virology. 1981 Nov;115(1):97–114. doi: 10.1016/0042-6822(81)90092-1. [DOI] [PubMed] [Google Scholar]
  24. Holden V. R., Caughman G. B., Zhao Y., Harty R. N., O'Callaghan D. J. Identification and characterization of the ICP22 protein of equine herpesvirus 1. J Virol. 1994 Jul;68(7):4329–4340. doi: 10.1128/jvi.68.7.4329-4340.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Holden V. R., Yalamanchili R. R., Harty R. N., O'Callaghan D. J. ICP22 homolog of equine herpesvirus 1: expression from early and late promoters. J Virol. 1992 Feb;66(2):664–673. doi: 10.1128/jvi.66.2.664-673.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Holden V. R., Zhao Y., Thompson Y., Caughman G. B., Smith R. H., O'Callaghan D. J. Characterization of the regulatory function of the ICP22 protein of equine herpesvirus type 1. Virology. 1995 Jul 10;210(2):273–282. doi: 10.1006/viro.1995.1344. [DOI] [PubMed] [Google Scholar]
  27. Huang A. S., Baltimore D. Defective viral particles and viral disease processes. Nature. 1970 Apr 25;226(5243):325–327. doi: 10.1038/226325a0. [DOI] [PubMed] [Google Scholar]
  28. Kozak M. The scanning model for translation: an update. J Cell Biol. 1989 Feb;108(2):229–241. doi: 10.1083/jcb.108.2.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kwong A. D., Frenkel N. Herpes simplex virus amplicon: effect of size on replication of constructed defective genomes containing eucaryotic DNA sequences. J Virol. 1984 Sep;51(3):595–603. doi: 10.1128/jvi.51.3.595-603.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Murray B. K., Biswal N., Bookout J. B., Lanford R. E., Courtney R. J., Melnick J. L. Cyclic appearance of defective interfering particles of herpes simplex virus and the concomitant accumulation of early polypeptide VP175. Intervirology. 1975;5(3-4):173–184. doi: 10.1159/000149894. [DOI] [PubMed] [Google Scholar]
  31. O'Callaghan D. J., Cheevers W. P., Gentry G. A., Randall C. C. Kinetics of cellular and viral DNA synthesis in equine abortion (herpes) virus infection of L-M cells. Virology. 1968 Sep;36(1):104–114. doi: 10.1016/0042-6822(68)90120-7. [DOI] [PubMed] [Google Scholar]
  32. O'Callaghan D. J., Hyde J. M., Gentry G. A., Randall C. C. Kinetics of viral deoxyribonucleic acid, protein, and infectious particle production and alterations in host macromolecular syntheses in equine abortion (herpes) virus-infected cells. J Virol. 1968 Aug;2(8):793–804. doi: 10.1128/jvi.2.8.793-804.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. O'Callaghan D. J., Randall C. C. Molecular anatomy of herpesviruses: recent studies. Prog Med Virol. 1976;22:152–210. [PubMed] [Google Scholar]
  34. Perdue M. L., Kemp M. C., Randall C. C., O'Callaghan D. J. Studies of the molecular anatomy of the L-M cell strain of equine herpes virus type 1: proteins of the nucleocapsid and intact virion. Virology. 1974 May;59(1):201–216. doi: 10.1016/0042-6822(74)90216-5. [DOI] [PubMed] [Google Scholar]
  35. RANDALL C. C., LAWSON L. A. Adaptation of equine abortion virus to Earle's L cells in serum-free medium with plaque formation. Proc Soc Exp Biol Med. 1962 Jul;110:487–489. doi: 10.3181/00379727-110-27558. [DOI] [PubMed] [Google Scholar]
  36. Rice S. A., Knipe D. M. Gene-specific transactivation by herpes simplex virus type 1 alpha protein ICP27. J Virol. 1988 Oct;62(10):3814–3823. doi: 10.1128/jvi.62.10.3814-3823.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Rice S. A., Knipe D. M. Genetic evidence for two distinct transactivation functions of the herpes simplex virus alpha protein ICP27. J Virol. 1990 Apr;64(4):1704–1715. doi: 10.1128/jvi.64.4.1704-1715.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Rice S. A., Su L. S., Knipe D. M. Herpes simplex virus alpha protein ICP27 possesses separable positive and negative regulatory activities. J Virol. 1989 Aug;63(8):3399–3407. doi: 10.1128/jvi.63.8.3399-3407.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Rixon F. J., Ben-Porat T. Structural evolution of the DNA of pseudorabies-defective viral particles. Virology. 1979 Aug;97(1):151–163. doi: 10.1016/0042-6822(79)90381-7. [DOI] [PubMed] [Google Scholar]
  40. Rixon F. J., Feldman L. T., Ben-Porat T. Expression of the genome of defective interfering pseudorabies virions in the presence or absence of helper functions provided by standard virus. J Gen Virol. 1980 Jan;46(1):119–138. doi: 10.1099/0022-1317-46-1-119. [DOI] [PubMed] [Google Scholar]
  41. Robinson R. A., Henry B. E., Duff R. G., O'Callaghan D. J. Oncogenic transformation by equine herpesviruses (EHV). I. Properties of hamster embryo cells transformed by ultraviolet-irradiated EHV-1. Virology. 1980 Mar;101(2):335–362. doi: 10.1016/0042-6822(80)90449-3. [DOI] [PubMed] [Google Scholar]
  42. Robinson R. A., Tucker P. W., Dauenhauer S. A., O'Callaghan D. J. Molecular cloning of equine herpesvirus type 1 DNA: analysis of standard and defective viral genomes and viral sequences in oncogenically transformed cells. Proc Natl Acad Sci U S A. 1981 Nov;78(11):6684–6688. doi: 10.1073/pnas.78.11.6684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Robinson R. A., Vance R. B., O'Callaghan D. J. Oncogenic transformation by by equine herpesviruses. II. Coestablishment of persistent infection and oncogenic transformation of hamster embryo cells by equine herpesvirus type 1 preparations enriched for defective interfering particles. J Virol. 1980 Oct;36(1):204–219. doi: 10.1128/jvi.36.1.204-219.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Rubenstein A. S., Kaplan A. S. Electron microscopic studies of the DNA of defective and standard pseudorabies virions. Virology. 1975 Aug;66(2):385–392. doi: 10.1016/0042-6822(75)90211-1. [DOI] [PubMed] [Google Scholar]
  45. Sekulovich R. E., Leary K., Sandri-Goldin R. M. The herpes simplex virus type 1 alpha protein ICP27 can act as a trans-repressor or a trans-activator in combination with ICP4 and ICP0. J Virol. 1988 Dec;62(12):4510–4522. doi: 10.1128/jvi.62.12.4510-4522.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Smith I. L., Hardwicke M. A., Sandri-Goldin R. M. Evidence that the herpes simplex virus immediate early protein ICP27 acts post-transcriptionally during infection to regulate gene expression. Virology. 1992 Jan;186(1):74–86. doi: 10.1016/0042-6822(92)90062-t. [DOI] [PubMed] [Google Scholar]
  47. Smith I. L., Sekulovich R. E., Hardwicke M. A., Sandri-Goldin R. M. Mutations in the activation region of herpes simplex virus regulatory protein ICP27 can be trans dominant. J Virol. 1991 Jul;65(7):3656–3666. doi: 10.1128/jvi.65.7.3656-3666.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Smith R. H., Zhao Y., O'Callaghan D. J. The equine herpesvirus 1 (EHV-1) UL3 gene, an ICP27 homolog, is necessary for full activation of gene expression directed by an EHV-1 late promoter. J Virol. 1993 Feb;67(2):1105–1109. doi: 10.1128/jvi.67.2.1105-1109.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Spaete R. R., Frenkel N. The herpes simplex virus amplicon: a new eucaryotic defective-virus cloning-amplifying vector. Cell. 1982 Aug;30(1):295–304. doi: 10.1016/0092-8674(82)90035-6. [DOI] [PubMed] [Google Scholar]
  50. Su L., Knipe D. M. Herpes simplex virus alpha protein ICP27 can inhibit or augment viral gene transactivation. Virology. 1989 Jun;170(2):496–504. doi: 10.1016/0042-6822(89)90441-8. [DOI] [PubMed] [Google Scholar]
  51. White K. A., Bancroft J. B., Mackie G. A. Coding capacity determines in vivo accumulation of a defective RNA of clover yellow mosaic virus. J Virol. 1992 May;66(5):3069–3076. doi: 10.1128/jvi.66.5.3069-3076.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Yalamanchili R. R., O'Callaghan D. J. Organization and function of the ORIs sequence in the genome of EHV-1 DI particles. Virology. 1990 Dec;179(2):867–870. doi: 10.1016/0042-6822(90)90157-m. [DOI] [PubMed] [Google Scholar]
  53. Yalamanchili R. R., O'Callaghan D. J. Sequence and organization of the genomic termini of equine herpesvirus type 1. Virus Res. 1990 Feb;15(2):149–161. doi: 10.1016/0168-1702(90)90005-v. [DOI] [PubMed] [Google Scholar]
  54. Yalamanchili R. R., Raengsakulrach B., Baumann R. P., O'Callaghan D. J. Identification of the site of recombination in the generation of the genome of DI particles of equine herpesvirus type 1. Virology. 1990 Apr;175(2):448–455. doi: 10.1016/0042-6822(90)90429-u. [DOI] [PubMed] [Google Scholar]
  55. Yalamanchili R. R., Raengsakulrach B., O'Callaghan D. J. Equine herpesvirus 1 sequence near the left terminus codes for two open reading frames. Virus Res. 1991 Mar;18(2-3):109–116. doi: 10.1016/0168-1702(91)90012-k. [DOI] [PubMed] [Google Scholar]
  56. Zhao Y., Holden V. R., Harty R. N., O'Callaghan D. J. Identification and transcriptional analyses of the UL3 and UL4 genes of equine herpesvirus 1, homologs of the ICP27 and glycoprotein K genes of herpes simplex virus. J Virol. 1992 Sep;66(9):5363–5372. doi: 10.1128/jvi.66.9.5363-5372.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Zhao Y., Holden V. R., Smith R. H., O'Callaghan D. J. Regulatory function of the equine herpesvirus 1 ICP27 gene product. J Virol. 1995 May;69(5):2786–2793. doi: 10.1128/jvi.69.5.2786-2793.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES